Related Experiment Video

Updated: Aug 29, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia

Takahide Teramoto1, Hideo Kaneko, Michinori Funato

  • 1Department of Pediatrics, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan. t-tera@cc.gifu-u.ac.jp

Scandinavian Journal of Infectious Diseases
|January 16, 2004
PubMed

Insights

This is the first reported case of progressive multifocal leukoencephalopathy (PML) in a patient with X-linked agammaglobulinemia. The study confirms JC virus infection as the cause in this unique immunodeficiency setting.

Area of Science:

  • Immunology
  • Neurology
  • Virology

Background:

  • X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by impaired B-cell development and function.
  • Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by the JC virus (JCV).
  • PML is typically seen in severely immunocompromised individuals.

Observation:

  • This case report details a patient with XLA who developed PML.
  • JC virus was identified as the causative agent of PML post-mortem.
  • The patient presented with humoral immunodeficiency while maintaining normal cellular immunity.

Findings:

  • This is the first documented instance of PML occurring in the context of X-linked agammaglobulinemia.
  • The findings suggest that JCV can infect individuals with specific types of immunodeficiency, even with preserved cellular immunity.
  • Autopsy confirmed the presence of JC virus and the diagnosis of PML.

Implications:

  • This case expands the understanding of PML pathogenesis and its potential association with various immunodeficiency disorders.
  • It highlights the importance of considering opportunistic infections like PML in patients with primary B-cell defects.
  • Further research is warranted to elucidate the mechanisms underlying JCV susceptibility in XLA and to inform clinical management strategies.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...